Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis

AG Herman, S Moncada - European heart journal, 2005 - academic.oup.com
Well-known risk factors for atherosclerosis include hypercholesterolaemia, hypertension,
diabetes, and smoking. These conditions are associated with endothelial dysfunction, which …

Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis

AG Herman, S Moncada - 0195-668X (Print) 0195 …, 2005 - escholar.manchester.ac.uk
Well-known risk factors for atherosclerosis include hypercholesterolaemia, hypertension,
diabetes, and smoking. These conditions are associated with endothelial dysfunction, which …

Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis.

AG Herman, S Moncada - European Heart Journal, 2005 - europepmc.org
Well-known risk factors for atherosclerosis include hypercholesterolaemia, hypertension,
diabetes, and smoking. These conditions are associated with endothelial dysfunction, which …

[引用][C] Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis

AG HERMAN, S MONCADA - European heart journal, 2005 - pascal-francis.inist.fr
Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …

Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis.

AG Herman, S Moncada - European Heart Journal, 2005 - search.ebscohost.com
Well-known risk factors for atherosclerosis include hypercholesterolaemia, hypertension,
diabetes, and smoking. These conditions are associated with endothelial dysfunction, which …

Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis

AG Herman, S Moncada - European heart journal …, 2005 - repository.uantwerpen.be
Well-known risk factors for atherosclerosis include hypercholesterolaemia, hypertension,
diabetes, and smoking. These conditions are associated with endothelial dysfunction, which …

Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis

AG Herman, S Moncada - European heart journal, 2005 - pubmed.ncbi.nlm.nih.gov
Well-known risk factors for atherosclerosis include hypercholesterolaemia, hypertension,
diabetes, and smoking. These conditions are associated with endothelial dysfunction, which …

[引用][C] Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis

AG Herman, S Moncada - European Heart Journal, 2005 - cir.nii.ac.jp
Therapeutic potential of nitric oxide donors in the prevention and treatment of
atherosclerosis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

[PDF][PDF] Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis

AG Herman, S Moncada - European Heart Journal, 2005 - Citeseer
The discovery of the endothelium-derived relaxing factor, its identification as nitric oxide
(NO) released by the vascular endothelium, and the elucidation of its biosynthetic pathway …

Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis

AG Herman, S Moncada - European Heart Journal, 2005 - research.manchester.ac.uk
Well-known risk factors for atherosclerosis include hypercholesterolaemia, hypertension,
diabetes, and smoking. These conditions are associated with endothelial dysfunction, which …